The expression level of FTO is elevated in HCC, which is promoted by the lncRNA FTO-IT1 recruiting interleukin enhancer binding factor 2 (ILF2) and 3 (ILF3) (52). Here, ILF2 is linked to hepatocellular carcinoma.